Sutro Biopharma STRO Prepaid & Other Current
Prepaid & Other Current at other companies
Other financials
Where this comes from
Reported directly by Sutro Biopharma in its filing.
Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.
The official record: Sutro Biopharma’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about Sutro Biopharma's prepaid & other current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Sutro Biopharma's prepaid & other current?
- Sutro Biopharma (STRO) reported prepaid & other current of $5.93M in Q1 2026.
- How has Sutro Biopharma's prepaid & other current changed year-over-year?
- Sutro Biopharma's prepaid & other current decreased by 76.2% year-over-year, from $24.88M to $5.93M.
- What is the long-term trend for Sutro Biopharma's prepaid & other current?
- Over 5 years (2020 to 2025), Sutro Biopharma's prepaid & other current has grown at a 4.2% compound annual growth rate (CAGR), from $4.49M to $5.52M.
- What does prepaid & other current mean?
- Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.